Aarey Drugs & Pharmaceuticals ne preferential warrants ko equity mein convert karke **1.15 million** naye shares allot kiye hain. Isse company ke paas **₹5.5 Crore** ka fresh fund aaya hai, lekin existing shareholders ke liye thoda dilution bhi ho gaya hai.
Equity ka naya math
Aarey Drugs ne September 30, 2026 ko board meeting mein 1,150,000 equity shares allot karne ka decision liya. Ye shares ₹63.80 per share ke price par issue huye hain, jisme ₹10 face value aur ₹53.80 premium shamil hai. Is move se company mein total ₹5,50,27,500 ka infusion hua hai.
Investors ke liye kya matlab hai?
Is allotment ke baad ab company ke total outstanding shares badhkar 31,874,303 ho gaye hain. Dekho, fund aana toh acchi baat hai, lekin jab naye shares aate hain, toh existing investors ki equity thodi dilute (kam) ho jati hai. Isliye EPS (Earnings Per Share) metrics par nazar rakhna zaroori ho gaya hai.
Warrant story abhi baaki hai
Company ne May 2025 mein total 5,000,000 convertible warrants issue kiye the. Ab tak 3,520,000 warrants convert ho chuke hain, aur abhi bhi 1,480,000 warrants bache hain. Inhe convert karne ke liye 18 mahine ki window mili thi, jo ab khatam hone ki taraf badh rahi hai.
Aage kya?
Ab aapko sirf ye track karna hai ki baki bache 1,480,000 warrants ka kya hota hai. Agar wo convert hote hain, toh equity base aur expand hoga. Official filings par nazar rakho, kyunki koi bhi further conversion share price aur earnings calculation par seedha asar dalega.